Table 1 Patient characteristics for EPS urine samples from cohorts A and B.

From: Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer

 

N

Mean age±s.e.m.

Gleason score range

Gleason score ( n)

BCR

Mets

Cohort A

 Controls

24

59.23±1.49

    

Normal

11

57.34±2.09

    

BPH

13

60.83±2.08

    

 Prostate cancer

50

58.9±0.92

    

Organ confined

37

57.9±1.04

6–8

6 (12)

0

0

    

7 (24)

  
    

8 (1)

  

Extracapsular

13

61.7±1.75

6–9

6 (1)

2

1

    

7 (11)

  
    

9 (1)

  

Cohort B

 Controls

117

60.15±0.77

    

Normal

48

58.33±1.36

    

BPH

69

61.41±0.87

    

 Prostate cancer

90

59.72±0.64

    

pT2

61

59.43±0.78

6–8

6 (23)

11

3

    

7 (37)

  
    

8 (1)

  

pT3

29

60.34±1.15

6–9

6 (2)

10

3

    

7 (23)

  
    

8 (1)

  
    

9 (2)

  
  1. BCR, biochemical recurrence; EPS, expressed prostatic secretion; Mets, metastasis.
Back to article page